Amphastar Pharma (AMPH)

Jan 8, 2025, 6:00 AM EST - 9 days ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 3, 2025, 12:48 PM EST - 14 days ago

Amphastar Pharmaceuticals: Cheap With Caveats

Nov 26, 2024, 4:05 PM EST - 7 weeks ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Nov 13, 2024, 4:05 PM EST - 2 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Nov 6, 2024, 9:12 PM EST - 2 months ago

Amphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:05 PM EST - 2 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Oct 29, 2024, 6:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Oct 2, 2024, 12:08 PM EDT - 3 months ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Sep 13, 2024, 7:20 AM EDT - 4 months ago

Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects

Aug 28, 2024, 4:10 PM EDT - 5 months ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Aug 19, 2024, 5:00 AM EDT - 5 months ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO

Aug 9, 2024, 7:47 PM EDT - 5 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:05 PM EDT - 5 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

Jun 14, 2024, 4:30 PM EDT - 7 months ago

BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC

MDT

Jun 4, 2024, 6:00 AM EDT - 8 months ago

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

Jun 3, 2024, 6:00 AM EDT - 8 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 2:06 AM EDT - 8 months ago

Amphastar Pharmaceuticals: Buy When Fear Is Overblown

May 20, 2024, 5:29 AM EDT - 8 months ago

Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth

May 9, 2024, 4:05 PM EDT - 9 months ago

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

May 8, 2024, 11:11 PM EDT - 9 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 9 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Apr 30, 2024, 4:05 PM EDT - 9 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Apr 1, 2024, 6:00 AM EDT - 10 months ago

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 6, 2024, 4:05 PM EST - 11 months ago

Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference

Mar 4, 2024, 1:37 PM EST - 11 months ago

Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions

Feb 29, 2024, 7:46 PM EST - 11 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 11 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

Feb 20, 2024, 4:01 PM EST - 11 months ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024

Jan 2, 2024, 6:00 AM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 20, 2023, 4:20 PM EST - 1 year ago

Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 8, 2023, 10:39 PM EST - 1 year ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:05 PM EST - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

Nov 1, 2023, 4:10 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

Oct 10, 2023, 9:41 PM EDT - 1 year ago

Amphastar Pharmaceuticals: Great Growth At A High Price

Sep 26, 2023, 7:00 AM EDT - 1 year ago

Amphastar: Dip, But No Slip, Rebound Playbook (Rating Upgrade)

Sep 13, 2023, 12:37 AM EDT - 1 year ago

Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes

Sep 11, 2023, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes

Aug 31, 2023, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

Aug 8, 2023, 8:35 PM EDT - 1 year ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

Aug 2, 2023, 4:10 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

Jul 12, 2023, 6:13 AM EDT - 1 year ago

Amphastar Pharma: A Company Growing Quickly As Acquisitions Likely Fuel Growth

Jun 30, 2023, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly

May 31, 2023, 4:15 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 13, 2023, 2:13 PM EDT - 1 year ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023

May 3, 2023, 4:30 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023

Apr 24, 2023, 6:54 AM EDT - 1 year ago

Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar

LLY

Apr 24, 2023, 6:45 AM EDT - 1 year ago

Lilly to Divest BAQSIMI to Amphastar

LLY